Logo image of BALY

BALLY'S CORP (BALY) Stock Fundamental Analysis

USA - NYSE:BALY - US05875B3042 - Common Stock

18.56 USD
+1.44 (+8.41%)
Last: 11/7/2025, 8:04:00 PM
18.56 USD
0 (0%)
After Hours: 11/7/2025, 8:04:00 PM
Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to BALY. BALY was compared to 132 industry peers in the Hotels, Restaurants & Leisure industry. Both the profitability and financial health of BALY have multiple concerns. BALY is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

BALY had negative earnings in the past year.
BALY had a positive operating cash flow in the past year.
BALY had negative earnings in each of the past 5 years.
In the past 5 years BALY always reported a positive cash flow from operatings.
BALY Yearly Net Income VS EBIT VS OCF VS FCFBALY Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M -400M

1.2 Ratios

BALY has a Return On Assets of -7.42%. This is amonst the worse of the industry: BALY underperforms 80.30% of its industry peers.
BALY has a Return On Equity of -91.83%. This is in the lower half of the industry: BALY underperforms 67.42% of its industry peers.
BALY has a Return On Invested Capital of 0.57%. This is in the lower half of the industry: BALY underperforms 76.52% of its industry peers.
Industry RankSector Rank
ROA -7.42%
ROE -91.83%
ROIC 0.57%
ROA(3y)-6.39%
ROA(5y)-4.24%
ROE(3y)-639.86%
ROE(5y)-385.68%
ROIC(3y)N/A
ROIC(5y)N/A
BALY Yearly ROA, ROE, ROICBALY Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500 -1K -1.5K

1.3 Margins

With a Operating Margin value of 1.99%, BALY is not doing good in the industry: 74.24% of the companies in the same industry are doing better.
BALY has a Gross Margin of 54.78%. This is in the better half of the industry: BALY outperforms 66.67% of its industry peers.
In the last couple of years the Gross Margin of BALY has declined.
Industry RankSector Rank
OM 1.99%
PM (TTM) N/A
GM 54.78%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.11%
GM growth 5Y-3.47%
BALY Yearly Profit, Operating, Gross MarginsBALY Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 60

0

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so BALY is destroying value.
Compared to 1 year ago, BALY has more shares outstanding
The number of shares outstanding for BALY has been increased compared to 5 years ago.
The debt/assets ratio for BALY is higher compared to a year ago.
BALY Yearly Shares OutstandingBALY Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
BALY Yearly Total Debt VS Total AssetsBALY Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

Based on the Altman-Z score of 0.30, we must say that BALY is in the distress zone and has some risk of bankruptcy.
BALY has a Altman-Z score of 0.30. This is in the lower half of the industry: BALY underperforms 78.79% of its industry peers.
BALY has a Debt/Equity ratio of 5.65. This is a high value indicating a heavy dependency on external financing.
With a Debt to Equity ratio value of 5.65, BALY is not doing good in the industry: 61.36% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 5.65
Debt/FCF N/A
Altman-Z 0.3
ROIC/WACC0.06
WACC8.89%
BALY Yearly LT Debt VS Equity VS FCFBALY Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B

2.3 Liquidity

BALY has a Current Ratio of 0.49. This is a bad value and indicates that BALY is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 0.49, BALY is doing worse than 75.76% of the companies in the same industry.
BALY has a Quick Ratio of 0.49. This is a bad value and indicates that BALY is not financially healthy enough and could expect problems in meeting its short term obligations.
BALY has a worse Quick ratio (0.47) than 73.48% of its industry peers.
Industry RankSector Rank
Current Ratio 0.49
Quick Ratio 0.47
BALY Yearly Current Assets VS Current LiabilitesBALY Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

4

3. Growth

3.1 Past

BALY shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -33.90%.
BALY shows a decrease in Revenue. In the last year, the revenue decreased by -1.10%.
BALY shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 36.16% yearly.
EPS 1Y (TTM)-33.9%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-203.23%
Revenue 1Y (TTM)-1.1%
Revenue growth 3Y22.83%
Revenue growth 5Y36.16%
Sales Q2Q%5.77%

3.2 Future

Based on estimates for the next years, BALY will show a very strong growth in Earnings Per Share. The EPS will grow by 22.94% on average per year.
BALY is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 6.76% yearly.
EPS Next Y64.07%
EPS Next 2Y34.22%
EPS Next 3Y22.94%
EPS Next 5YN/A
Revenue Next Year3.75%
Revenue Next 2Y5.25%
Revenue Next 3Y6.76%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
BALY Yearly Revenue VS EstimatesBALY Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1B 2B 3B
BALY Yearly EPS VS EstimatesBALY Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 -2 -4 -6 -8 -10

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for BALY. In the last year negative earnings were reported.
Also next year BALY is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BALY Price Earnings VS Forward Price EarningsBALY Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of BALY is on the same level as its industry peers.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 11.55
BALY Per share dataBALY EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 40 -40 -60

4.3 Compensation for Growth

BALY's earnings are expected to grow with 22.94% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y34.22%
EPS Next 3Y22.94%

0

5. Dividend

5.1 Amount

BALY does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

BALLY'S CORP

NYSE:BALY (11/7/2025, 8:04:00 PM)

After market: 18.56 0 (0%)

18.56

+1.44 (+8.41%)

Chartmill FA Rating
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)11-04 2025-11-04/bmo
Earnings (Next)03-03 2026-03-03/amc
Inst Owners75.35%
Inst Owner Change1.17%
Ins Owners12.56%
Ins Owner Change0.42%
Market Cap911.67M
Revenue(TTM)2.46B
Net Income(TTM)-578.59M
Analysts50
Price Target13.11 (-29.36%)
Short Float %0.61%
Short Ratio1.55
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-712.79%
Min EPS beat(2)-1443.99%
Max EPS beat(2)18.41%
EPS beat(4)1
Avg EPS beat(4)-1094.62%
Min EPS beat(4)-2765.33%
Max EPS beat(4)18.41%
EPS beat(8)2
Avg EPS beat(8)-779.41%
EPS beat(12)2
Avg EPS beat(12)-863.1%
EPS beat(16)4
Avg EPS beat(16)-655.13%
Revenue beat(2)0
Avg Revenue beat(2)-2.3%
Min Revenue beat(2)-4.31%
Max Revenue beat(2)-0.29%
Revenue beat(4)0
Avg Revenue beat(4)-3.46%
Min Revenue beat(4)-5.87%
Max Revenue beat(4)-0.29%
Revenue beat(8)0
Avg Revenue beat(8)-3.49%
Revenue beat(12)0
Avg Revenue beat(12)-2.89%
Revenue beat(16)0
Avg Revenue beat(16)-4.47%
PT rev (1m)3.21%
PT rev (3m)-5.86%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-110.63%
EPS NY rev (1m)0%
EPS NY rev (3m)-154.08%
Revenue NQ rev (1m)-0.05%
Revenue NQ rev (3m)0.02%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.39%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.37
P/FCF N/A
P/OCF 17.23
P/B 1.45
P/tB N/A
EV/EBITDA 11.55
EPS(TTM)-11.1
EYN/A
EPS(NY)-2.32
Fwd EYN/A
FCF(TTM)-4.62
FCFYN/A
OCF(TTM)1.08
OCFY5.8%
SpS50.02
BVpS12.83
TBVpS-61.71
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -7.42%
ROE -91.83%
ROCE 0.72%
ROIC 0.57%
ROICexc 0.58%
ROICexgc 1.3%
OM 1.99%
PM (TTM) N/A
GM 54.78%
FCFM N/A
ROA(3y)-6.39%
ROA(5y)-4.24%
ROE(3y)-639.86%
ROE(5y)-385.68%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.11%
GM growth 5Y-3.47%
F-Score6
Asset Turnover0.32
Health
Industry RankSector Rank
Debt/Equity 5.65
Debt/FCF N/A
Debt/EBITDA 9.52
Cap/Depr 85.99%
Cap/Sales 11.38%
Interest Coverage 0.16
Cash Conversion 14.15%
Profit Quality N/A
Current Ratio 0.49
Quick Ratio 0.47
Altman-Z 0.3
F-Score6
WACC8.89%
ROIC/WACC0.06
Cap/Depr(3y)125.58%
Cap/Depr(5y)105.92%
Cap/Sales(3y)17.68%
Cap/Sales(5y)13.89%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-33.9%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-203.23%
EPS Next Y64.07%
EPS Next 2Y34.22%
EPS Next 3Y22.94%
EPS Next 5YN/A
Revenue 1Y (TTM)-1.1%
Revenue growth 3Y22.83%
Revenue growth 5Y36.16%
Sales Q2Q%5.77%
Revenue Next Year3.75%
Revenue Next 2Y5.25%
Revenue Next 3Y6.76%
Revenue Next 5YN/A
EBIT growth 1Y260.61%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year376.88%
EBIT Next 3Y72.27%
EBIT Next 5YN/A
FCF growth 1Y18.85%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-68.67%
OCF growth 3Y11.25%
OCF growth 5Y3.91%

BALLY'S CORP / BALY FAQ

What is the ChartMill fundamental rating of BALLY'S CORP (BALY) stock?

ChartMill assigns a fundamental rating of 2 / 10 to BALY.


What is the valuation status of BALLY'S CORP (BALY) stock?

ChartMill assigns a valuation rating of 1 / 10 to BALLY'S CORP (BALY). This can be considered as Overvalued.


How profitable is BALLY'S CORP (BALY) stock?

BALLY'S CORP (BALY) has a profitability rating of 2 / 10.


Can you provide the expected EPS growth for BALY stock?

The Earnings per Share (EPS) of BALLY'S CORP (BALY) is expected to grow by 64.07% in the next year.


Can you provide the dividend sustainability for BALY stock?

The dividend rating of BALLY'S CORP (BALY) is 0 / 10 and the dividend payout ratio is 0%.